Parkinson’s

New predictive tool may identify the risk of dementia within Parkinson’s

The Montreal Parkinson Risk of Dementia Scale (MoPaRDS), which comprises 8 simple clinical variables, is effective for predicting the risk for dementia in patients with Parkinson disease(PD), according to findings from a multicenter study published in JAMA Neurology.

Read More >>

Huntington’s disease dementia may hold clues for Alzheimer’s

The buildup of a specific chemical in the brain is an early sign of Huntington's dementia, and it could help with early detection of Alzheimer's disease and other dementias, says a new study.

Read More >>

A new approach for treating Parkinson’s psychosis

Recent findings offer more support for primavanserin, an antipsychotic that works more effectively than other widely-used drugs—and without the damaging side effects. 

Read More >>

Dining with dignity

A Massachusetts couple sent diningware back to the drawing board to help older adults retain independence longer.

Read More >>

The benefits of dysphagia evaluations

Speech language pathologists outline the advantages of instrumental evaluations to capture residents’ swallowing abilities for diagnosing dysphagia. 

Read More >>

Faulty sense of smell can be indicator of dementia

A Canadian study has connected memory loss and a confused nose. Could it lead to earlier detection of Alzheimer’s disease? 

Read More >>

Mayo: Residents with Parkinson’s need melanoma screenings

Those with the movement disorder are nearly four times more likely to have skin cancer in their history, while those who have had skin cancer may have a higher risk of developing Parkinson's disease, a new study finds.

Read More >>

Cleveland Clinic launches $6M consortium to research Lewy Body dementia

Does Lewy Body Dementia have a biological calling card? Cleveland Clinic is launching a national consortium to find out.

Read More >>

Dementia vs. delirium

Although the terms are sometimes confused among lay people, the two conditions often develop independently from each other. Having both can cause the fastest decline of all, a new study shows.

Read More >>

Medicaid, Medicare and Mary Jane

Surprise—states that have legalized medical marijuana have far lower Medicaid and Medicare Part D prescription costs for certain chronic conditions, say recent studies. Will this get CMS' attention?

Read More >>